239 related articles for article (PubMed ID: 30927362)
1. Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
Durante V; de Iure A; Loffredo V; Vaikath N; De Risi M; Paciotti S; Quiroga-Varela A; Chiasserini D; Mellone M; Mazzocchetti P; Calabrese V; Campanelli F; Mechelli A; Di Filippo M; Ghiglieri V; Picconi B; El-Agnaf OM; De Leonibus E; Gardoni F; Tozzi A; Calabresi P
Brain; 2019 May; 142(5):1365-1385. PubMed ID: 30927362
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit.
Tozzi A; de Iure A; Bagetta V; Tantucci M; Durante V; Quiroga-Varela A; Costa C; Di Filippo M; Ghiglieri V; Latagliata EC; Wegrzynowicz M; Decressac M; Giampà C; Dalley JW; Xia J; Gardoni F; Mellone M; El-Agnaf OM; Ardah MT; Puglisi-Allegra S; Björklund A; Spillantini MG; Picconi B; Calabresi P
Biol Psychiatry; 2016 Mar; 79(5):402-414. PubMed ID: 26392130
[TBL] [Abstract][Full Text] [Related]
3. Synaptic dysfunction in Parkinson's disease.
Picconi B; Piccoli G; Calabresi P
Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
[TBL] [Abstract][Full Text] [Related]
4. Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.
Diógenes MJ; Dias RB; Rombo DM; Vicente Miranda H; Maiolino F; Guerreiro P; Näsström T; Franquelim HG; Oliveira LM; Castanho MA; Lannfelt L; Bergström J; Ingelsson M; Quintas A; Sebastião AM; Lopes LV; Outeiro TF
J Neurosci; 2012 Aug; 32(34):11750-62. PubMed ID: 22915117
[TBL] [Abstract][Full Text] [Related]
5. Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease.
Giordano N; Iemolo A; Mancini M; Cacace F; De Risi M; Latagliata EC; Ghiglieri V; Bellenchi GC; Puglisi-Allegra S; Calabresi P; Picconi B; De Leonibus E
Brain; 2018 Feb; 141(2):505-520. PubMed ID: 29281030
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
[TBL] [Abstract][Full Text] [Related]
7. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
8. CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.
Nouhi M; Zhang X; Yao N; Chergui K
CNS Neurosci Ther; 2018 Feb; 24(2):144-153. PubMed ID: 29230960
[TBL] [Abstract][Full Text] [Related]
9. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
[TBL] [Abstract][Full Text] [Related]
10. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.
Watson JB; Hatami A; David H; Masliah E; Roberts K; Evans CE; Levine MS
Neuroscience; 2009 Mar; 159(2):501-13. PubMed ID: 19361478
[TBL] [Abstract][Full Text] [Related]
11. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.
Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M
Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
13. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.
Lam HA; Wu N; Cely I; Kelly RL; Hean S; Richter F; Magen I; Cepeda C; Ackerson LC; Walwyn W; Masliah E; Chesselet MF; Levine MS; Maidment NT
J Neurosci Res; 2011 Jul; 89(7):1091-102. PubMed ID: 21488084
[TBL] [Abstract][Full Text] [Related]
14. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor.
Wang Y; Chen T; Yuan Z; Zhang Y; Zhang B; Zhao L; Chen L
Neuropharmacology; 2018 Sep; 139():257-267. PubMed ID: 29578035
[TBL] [Abstract][Full Text] [Related]
15. Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias.
Stanic J; Mellone M; Napolitano F; Racca C; Zianni E; Minocci D; Ghiglieri V; Thiolat ML; Li Q; Longhi A; De Rosa A; Picconi B; Bezard E; Calabresi P; Di Luca M; Usiello A; Gardoni F
Neurobiol Dis; 2017 Dec; 108():54-64. PubMed ID: 28823933
[TBL] [Abstract][Full Text] [Related]
16. Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression.
Mancini M; Ghiglieri V; Bagetta V; Pendolino V; Vannelli A; Cacace F; Mineo D; Calabresi P; Picconi B
Neuropharmacology; 2016 Feb; 101():341-50. PubMed ID: 26471421
[TBL] [Abstract][Full Text] [Related]
17. Bi-directional changes in synaptic plasticity induced at corticostriatal synapses in vitro.
Spencer JP; Murphy KP
Exp Brain Res; 2000 Dec; 135(4):497-503. PubMed ID: 11156313
[TBL] [Abstract][Full Text] [Related]
18. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors.
Calabresi P; Saiardi A; Pisani A; Baik JH; Centonze D; Mercuri NB; Bernardi G; Borrelli E
J Neurosci; 1997 Jun; 17(12):4536-44. PubMed ID: 9169514
[TBL] [Abstract][Full Text] [Related]
19. Synaptic dysfunction in Parkinson's disease.
Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
[TBL] [Abstract][Full Text] [Related]
20. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
